BioCardia outlines imminent CardiAMP FDA submission and targets regulatory catalysts as trial data signals clinical benefit (NAS

BioCardia outlines imminent CardiAMP FDA submission and targets regulatory catalysts as trial data signals clinical benefit (NASDAQ:BCDA)

March 24, 2026

Earnings Call Insights: BioCardia (BCDA) Q4 2025 Management View Peter Altman, CEO, highlighted that BioCardia now has complete and final ...

edit post

Fractyl Health outlines 2026 De Novo submission plans with pivotal Revita data expected in early Q4 (NASDAQ:GUTS)

by TheAdviserMagazine

March 24, 2026

0

Follow us on Google for the latest stock newsFollow Seeking Alpha on Google for the latest stock newsEarnings Call Insights: ...

edit post

Sera Prognostics outlines plan to expand partner programs to 15–17 states by year-end 2026 while maintaining cash runway through 2028 (NASDAQ:SERA)

by TheAdviserMagazine

March 18, 2026

0

Earnings Call Insights: Sera Prognostics (SERA) Q4 2025 Management View President and CEO Evguenia Lindgardt highlighted 2025 as a pivotal ...

edit post

Townsquare Media outlines high single-digit digital advertising growth for 2026 while strengthening programmatic partnerships (NYSE:TSQ)

by TheAdviserMagazine

March 16, 2026

0

Follow us on Google for the latest stock newsFollow Seeking Alpha on Google for the latest stock newsEarnings Call Insights: ...

edit post

QuidelOrtho outlines .7B–.9B 2026 revenue target as company advances R&D pipeline and margin expansion (NASDAQ:QDEL)

QuidelOrtho outlines $2.7B–$2.9B 2026 revenue target as company advances R&D pipeline and margin expansion (NASDAQ:QDEL)

by TheAdviserMagazine

February 11, 2026

0

Earnings Call Insights: QuidelOrtho Corporation (QDEL) Q4 2025 Management View CEO Brian Blaser reflected on his tenure since joining in ...

edit post

FCA Outlines Final Crypto Framework, Seeks Feedback on Governance and Consumer Duty

by TheAdviserMagazine

January 23, 2026

0

Blueberry Broker Review 2026: Regulation, Platforms, Fees & Trading Conditions | Finance Magnates Blueberry Broker Review 2026: Regulation, Platforms, Fees ...

edit post

Coinbase Outlines Bullish Markets Outlook as Global Liquidity and Scale Accelerate

by TheAdviserMagazine

January 10, 2026

0

Coinbase is accelerating its push to dominate global crypto trading, fueled by surging liquidity, expanding derivatives and spot markets, and ...

edit post

Analyst Outlines The Bull Case For XRP And Why Price Will Hit All-Time High Soon

by TheAdviserMagazine

January 10, 2026

0

XRP is now back to trading just above the $2 level after an early January rally briefly carried its price ...

edit post

Destination XL outlines M synergy target and merger-driven transformation with FullBeauty (NASDAQ:DXLG)

Destination XL outlines $25M synergy target and merger-driven transformation with FullBeauty (NASDAQ:DXLG)

by TheAdviserMagazine

December 12, 2025

0

Earnings Call Insights: Destination XL Group, Inc. (DXLG) Q3 2025 Management View Harvey Kanter, President, CEO & Director, highlighted a ...

edit post

Lovesac outlines fiscal 2026 guidance with $685M–$705M net sales target while focusing on core brand and domestic manufacturing (NASDAQ:LOVE)

by TheAdviserMagazine

December 11, 2025

0

Earnings Call Insights: The Lovesac Company (LOVE) Q3 2026 Management View CEO Shawn Nelson opened by stating that "macro conditions ...

Tag: Outlines